The Global HIV/AIDS Vaccine Enterprise: Scientific Strategic Plan
Open Access
- 18 January 2005
- journal article
- policy forum
- Published by Public Library of Science (PLoS) in PLoS Medicine
- Vol. 2 (2) , e25
- https://doi.org/10.1371/journal.pmed.0020025
Abstract
The development of an HIV vaccine remains one of the most difficult challenges confronting biomedical research today. A new international collaboration shares its plan to address the challenge.Keywords
This publication has 27 references indexed in Scilit:
- G8 Leaders Endorse Global EffortScience, 2004
- Modulating vaccine responses with dendritic cells and Toll‐like receptorsImmunological Reviews, 2004
- The Sudden Death of a Coral ReefScience, 2004
- Innate Immunity in Human Immunodeficiency Virus Infection: Effect of Viremia on Natural Killer Cell FunctionThe Journal of Infectious Diseases, 2003
- Antibody neutralization and escape by HIV-1Nature, 2003
- Slowly Declining Levels of Viral RNA and DNA in DNA/Recombinant Modified Vaccinia Virus Ankara-Vaccinated Macaques with Controlled Simian-Human Immunodeficiency Virus SHIV-89.6P ChallengesJournal of Virology, 2002
- Evidence of HIV-1 Adaptation to HLA-Restricted Immune Responses at a Population LevelScience, 2002
- Clinical Trials of HIV VaccinesAnnual Review of Medicine, 2002
- Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunityNature, 2002
- Live Attenuated HIV Vaccines: A Proposal for Further Research and DevelopmentAIDS Research and Human Retroviruses, 2000